Welltower stock reports strong Q2 growth as revenue rises

Welltower stock stood at USD 229.94 on the NYSE on September 23, 2026, placing it 9.9 percent below its 52-week high of USD 255.20. The healthcare real estate investment trust enters its next reporting cycle after a revenue surge in Q2 2026.

Revenue grows by 39.1 percent

According to MarketBeat, Welltower reported Q2 2026 revenue of USD 3.54 billion on July 27, 2026, up 39.1 percent from the same period a year earlier. The comparison gives the growth story a clear operating dimension rather than relying only on share-price performance.

The quarter also produced diluted EPS of USD 0.61, while the consensus estimate stood at USD 0.66. That USD 0.05 shortfall contrasts with the revenue beat against the USD 3.40 billion estimate cited by MarketBeat, making the earnings mix more important than the headline revenue figure alone.

Next report comes October 26

Welltower's investor-relations page lists its Q2 2026 results and identifies the company's seniors housing, post-acute care and outpatient medical property platform as its core operating base. The company also says it has completed more than USD 48 billion of investments since Q4 2020, a capital-allocation figure that helps explain the scale behind current revenue growth.

Morningstar reports that Welltower will release Q3 2026 results after the NYSE close on October 26, 2026, followed by a conference call on October 27, 2026, at 9:00 a.m. ET. That date is the next concrete checkpoint for testing whether revenue momentum can continue while per-share earnings catch up.

Stock remains below yearly high

Welltower's market capitalization was USD 165,688,328,209 on September 23, 2026. The stock's USD 229.94 price was above the 52-week low of USD 163.75 but remained below the yearly high, leaving the Q3 report as the next scheduled company-specific valuation test.